Instil Bio (TIL) Interest Expenses (2020 - 2026)
Instil Bio (TIL) posted quarterly Interest Expenses of $1.6 million for Q1 2026, up 41.35% year-over-year from $1.1 million in Q1 2025, and down 0.96% quarter-over-quarter from $1.6 million in Q4 2025.
Instil Bio (TIL) Interest Expenses (2020 - 2026) Analysis & Trends
Instil Bio's Interest Expenses history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 41.35% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $6.3 million (down 22.51% YoY), while the FY2025 annual figure was $5.8 million, down 95.88% from the prior year.
- Interest Expenses for Q1 2026 stood at $1.6 million, down from $1.6 million in the prior quarter.
- The five-year high for Interest Expenses was $3.4 million in Q4 2023, with the low at $331000.0 in Q2 2022.
- The 5-year median for Interest Expenses is $1.6 million (2025), against an average of $1.7 million.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses slumped 99.89% in 2022, then jumped 238.81% in 2024.
- Instil Bio's Interest Expenses stood at $2.1 million in 2022, then surged by 60.85% to $3.4 million in 2023, then decreased by 11.91% to $3.0 million in 2024, then slumped by 47.84% to $1.6 million in 2025, then declined by 0.96% to $1.6 million in 2026.
- Business Quant data shows TIL's Interest Expenses at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | 1.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.65 Mn |
| Jun 30, 2026 | 2.65 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.98 Mn |